NPPA and Hepatic steatosis: Furthermore, the exogenous administration of ANP ameliorates HFD-induced insulin and glucose tolerance through inter-organ metabolic crosstalk, even without any changes in body weight, namely by attenuating hepatic steatosis and inducing adipose tissue browning (activation of the adipose tissue thermogenic program).